Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 14.42%162.6M | 5.82%102.13M | -14.36%46.3M | -18.45%182.2M | -16.68%142.11M | -7.54%96.51M | 12.54%54.07M | -41.22%223.41M | -44.66%170.55M | -47.60%104.39M |
| Refunds of taxes and levies | 9.27%11.45M | 11.81%6.39M | 38.47%2.64M | -26.74%12.89M | -22.22%10.48M | -54.28%5.71M | 66.89%1.91M | -34.78%17.59M | -45.53%13.48M | 9.43%12.5M |
| Net deposit increase | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net increase in borrowings from central bank | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net increase in placements from other financial institutions | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash received from interests, fees and commissions | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net increase in repurchase business capital | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Premiums received from original insurance contracts | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net cash received from reinsurance business | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net increase in deposits from policyholders | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net increase in funds disbursed | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net cash received from trading securities | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash received relating to other operating activities | -35.79%8.5M | -37.46%6.03M | -81.35%1.22M | -28.41%19.96M | -42.52%13.25M | -29.22%9.64M | -24.16%6.52M | 99.82%27.88M | 212.19%23.04M | 157.53%13.62M |
| Cash inflows from operating activities | 10.08%182.56M | 2.39%114.54M | -19.73%50.16M | -20.02%215.04M | -19.91%165.83M | -14.28%111.86M | 8.15%62.49M | -36.14%268.88M | -39.16%207.07M | -39.56%130.5M |
| Goods services cash paid | -9.34%63.46M | -19.27%35.32M | -29.30%16.24M | 22.41%87.31M | 19.11%70M | 15.23%43.75M | 26.55%22.97M | -16.45%71.32M | -12.08%58.77M | -25.41%37.97M |
| Staff behalf paid | 8.24%121.15M | 7.28%82.99M | 10.42%49.14M | 9.18%142.73M | 13.28%111.93M | 12.79%77.36M | 5.95%44.5M | 13.13%130.73M | 14.38%98.81M | 8.66%68.59M |
| All taxes paid | -5.64%13.27M | -20.09%7.49M | -0.67%3.98M | 32.87%20.77M | 11.90%14.06M | 8.14%9.37M | 1.83%4.01M | -67.55%15.63M | -72.57%12.57M | -65.98%8.66M |
| Net loan and advance increase | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net deposit in central bank and institutions | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Net lend capital | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash paid for fees and commissions | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash paid for indemnity of original insurance contract | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Policy dividend cash paid | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| Cash paid relating to other operating activities | 1.72%24.93M | 0.86%15.08M | -20.15%6.57M | 5.95%35.19M | -7.12%24.51M | -3.22%14.95M | 11.26%8.22M | 18.25%33.21M | 36.51%26.39M | 41.39%15.45M |
| Cash outflows from operating activities | 1.05%222.81M | -3.13%140.87M | -4.74%75.93M | 13.99%285.99M | 12.20%220.5M | 11.30%145.43M | 11.50%79.71M | -9.48%250.9M | -10.00%196.53M | -13.13%130.66M |
| Net cash flows from operating activities | 26.36%-40.25M | 21.56%-26.33M | -49.70%-25.77M | -494.48%-70.95M | -618.76%-54.67M | -20,774.58%-33.56M | -25.63%-17.21M | -87.50%17.98M | -91.36%10.54M | -100.25%-160.78K |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 411.81%1.23B | 1,415.99%901.68M | 1,193.47%570.5M | 11,815.88%917.98M | --239.48M | --59.48M | --44.11M | -22.96%7.7M | ---- | ---- |
| Cash received from returns on investments | 8,119.51%4.83M | 6,541.75%3.9M | 3,794.39%2.29M | 456.76%4.04M | -88.03%58.73K | -81.44%58.73K | -65.56%58.73K | -11.42%725.35K | -24.10%490.66K | -33.00%316.37K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 97.65%92.5K | 97.65%92.5K | ---- | 2,320.65%44.92K | --46.8K | --46.8K | --46.8K | --1.86K | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash inflows from investing activities | 413.64%1.23B | 1,420.01%905.67M | 1,195.55%572.79M | 10,836.52%922.06M | 48,728.73%239.58M | 18,733.38%59.58M | 25,830.69%44.21M | -22.07%8.43M | -95.39%490.66K | -96.98%316.37K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -52.05%9.73M | -75.58%3.67M | -85.23%1.64M | -57.79%21.11M | -48.55%20.29M | -27.40%15.02M | 230.93%11.09M | 330.42%50.02M | 872.81%39.43M | 1,187.64%20.69M |
| Cash paid to acquire investments | 65.46%1.11B | 202.43%709.04M | 531.65%186M | 9,055.42%1.72B | --669.05M | --234.45M | --29.45M | --18.76M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Impawned loan net increase | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --0 | --0 | ---- | --0 | --941.51K | --941.51K | --0 | ---- | ---- | ---- |
| Cash outflows from investing activities | 61.78%1.12B | 184.61%712.71M | 362.89%187.64M | 2,427.84%1.74B | 1,650.62%690.28M | 1,110.01%250.41M | 1,109.67%40.54M | 491.85%68.78M | 872.81%39.43M | 1,187.64%20.69M |
| Net cash flows from investing activities | 125.26%113.83M | 201.12%192.97M | 10,378.53%385.15M | -1,253.12%-816.6M | -1,057.41%-450.7M | -836.41%-190.83M | 215.57%3.68M | -7,420.71%-60.35M | -690.61%-38.94M | -329.88%-20.38M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 384.41%27.39M | 326.95%24.14M | ---- | --5.65M | --5.65M | --5.65M | --5.65M | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash from borrowing | --8.71M | --5.79M | --3.01M | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other financing activities | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash inflows from financing activities | 538.47%36.1M | 429.29%29.93M | -46.74%3.01M | --5.65M | --5.65M | --5.65M | --5.65M | ---- | ---- | ---- |
| Borrowing repayment | --61.54K | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Dividend interest payment | 55.47%18.25M | 54.97%18.19M | --5.71K | -91.42%12.91M | -92.20%11.74M | -92.20%11.74M | --0 | 60,287.05%150.45M | 81,374.67%150.53M | 249,372.34%150.53M |
| -Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 395.02%24.99M | 6,610.09%24.99M | --24.99M | 77.28%7.22M | --5.05M | --372.45K | --0 | -81.25%4.07M | ---- | ---- |
| Cash outflows from financing activities | 157.94%43.31M | 256.52%43.19M | --25M | -86.97%20.13M | -88.85%16.79M | -91.95%12.11M | --0 | 603.28%154.52M | 43.15%150.53M | 10,471.38%150.53M |
| Net cash flows from financing activities | 35.27%-7.21M | -105.29%-13.26M | -488.86%-21.99M | 90.63%-14.47M | 92.60%-11.14M | 95.71%-6.46M | --5.65M | -115.29%-154.52M | -114.83%-150.53M | -10,471.38%-150.53M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,547.99%-533.87K | -158.13%-154.4K | -113.64%-24.41K | 67.62%372.85K | -113.44%-32.4K | -6.34%265.6K | 175.67%179.02K | -89.89%222.44K | -83.78%241.1K | -65.31%283.58K |
| Net increase in cash and cash equivalents | 112.75%65.84M | 166.45%153.22M | 4,478.68%337.37M | -358.47%-901.65M | -189.06%-516.53M | -35.01%-230.58M | 54.99%-7.7M | -117.01%-196.67M | -115.60%-178.69M | -331.48%-170.79M |
| Add:Begin period cash and cash equivalents | -77.40%263.34M | -77.40%263.34M | -77.40%263.34M | -14.44%1.16B | -14.44%1.16B | -14.44%1.16B | -14.44%1.16B | 562.06%1.36B | 562.06%1.36B | 562.06%1.36B |
| End period cash equivalent | -49.24%329.18M | -55.42%416.57M | -48.09%600.71M | -77.40%263.34M | -45.18%648.46M | -21.54%934.41M | -13.93%1.16B | -14.44%1.16B | -12.43%1.18B | 326.14%1.19B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.